NASDAQ:PETS - Petmed Express Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$37.94 +0.73 (+1.96 %)
(As of 05/25/2018 04:00 PM ET)
Previous Close$37.21
Today's Range$37.21 - $38.20
52-Week Range$31.81 - $57.80
Volume376,000 shs
Average Volume641,031 shs
Market Capitalization$766.57 million
P/E Ratio20.44
Dividend Yield2.69%
Beta1.03

About Petmed Express (NASDAQ:PETS)

Petmed Express logoPetMed Express, Inc. and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats to retail customers. It provides non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, thyroid, diabetes, pain medications, antibiotics, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, strollers, and other pet supplies through its Website. It markets its products through Internet; telephone contact center; and direct mail/print through 1-800-PetMeds catalogs, brochures, and postcards under various brands. PetMed Express, Inc. was founded in 1996 and is headquartered in Delray Beach, Florida.

Receive PETS News and Ratings via Email

Sign-up to receive the latest news and ratings for PETS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drug stores & proprietary stores
Sub-IndustryInternet Retail
SectorRetail/Wholesale
SymbolNASDAQ:PETS
CUSIP71638210
Phone561-526-4444

Debt

Debt-to-Equity RatioN/A
Current Ratio5.81
Quick Ratio4.52

Price-To-Earnings

Trailing P/E Ratio20.44
Forward P/E Ratio16.64
P/E Growth1.63

Sales & Book Value

Annual Sales$273.80 million
Price / Sales2.85
Cash Flow$1.9506 per share
Price / Cash19.45
Book Value$5.62 per share
Price / Book6.75

Profitability

EPS (Most Recent Fiscal Year)$1.82
Net Income$37.28 million
Net Margins13.62%
Return on Equity34.76%
Return on Assets28.63%

Miscellaneous

Employees187
Outstanding Shares20,600,000

Petmed Express (NASDAQ:PETS) Frequently Asked Questions

What is Petmed Express' stock symbol?

Petmed Express trades on the NASDAQ under the ticker symbol "PETS."

How often does Petmed Express pay dividends? What is the dividend yield for Petmed Express?

Petmed Express declared a quarterly dividend on Monday, May 7th. Investors of record on Friday, May 18th will be given a dividend of $0.25 per share on Friday, May 25th. This represents a $1.00 dividend on an annualized basis and a yield of 2.64%. The ex-dividend date is Thursday, May 17th. View Petmed Express' Dividend History.

How were Petmed Express' earnings last quarter?

Petmed Express Inc (NASDAQ:PETS) posted its earnings results on Monday, May, 7th. The company reported $0.50 EPS for the quarter, topping analysts' consensus estimates of $0.47 by $0.03. The firm earned $67.30 million during the quarter, compared to the consensus estimate of $68.43 million. Petmed Express had a net margin of 13.62% and a return on equity of 34.76%. The company's quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter last year, the business posted $0.37 EPS. View Petmed Express' Earnings History.

When is Petmed Express' next earnings date?

Petmed Express is scheduled to release their next quarterly earnings announcement on Monday, July, 23rd 2018. View Earnings Estimates for Petmed Express.

What price target have analysts set for PETS?

5 analysts have issued 1 year price objectives for Petmed Express' shares. Their predictions range from $19.00 to $58.00. On average, they expect Petmed Express' stock price to reach $40.50 in the next year. View Analyst Ratings for Petmed Express.

Who are some of Petmed Express' key competitors?

Who are Petmed Express' key executives?

Petmed Express' management team includes the folowing people:
  • Mr. Menderes Akdag, Chief Exec. Officer, Pres & Director (Age 57)
  • Mr. Bruce S. Rosenbloom, CFO, Principal Accounting Officer & Treasurer (Age 49)
  • Ms. Alison Berges, Corp. Sec. & Gen. Counsel

Has Petmed Express been receiving favorable news coverage?

Media coverage about PETS stock has trended somewhat positive recently, according to Accern Sentiment. The research group ranks the sentiment of news coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Petmed Express earned a news sentiment score of 0.06 on Accern's scale. They also assigned media headlines about the company an impact score of 44.36 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the near term.

Who are Petmed Express' major shareholders?

Petmed Express' stock is owned by a variety of of institutional and retail investors. Top institutional investors include Redwood Investments LLC (1.56%). Company insiders that own Petmed Express stock include Bruce S Rosenbloom, Frank J Formica, Gian Fulgoni, Menderes Akdag, Robert C Schweitzer and Ronald J Korn. View Institutional Ownership Trends for Petmed Express.

Which major investors are buying Petmed Express stock?

PETS stock was purchased by a variety of institutional investors in the last quarter, including Redwood Investments LLC. View Insider Buying and Selling for Petmed Express.

How do I buy shares of Petmed Express?

Shares of PETS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Petmed Express' stock price today?

One share of PETS stock can currently be purchased for approximately $37.94.

How big of a company is Petmed Express?

Petmed Express has a market capitalization of $766.57 million and generates $273.80 million in revenue each year. The company earns $37.28 million in net income (profit) each year or $1.82 on an earnings per share basis. Petmed Express employs 187 workers across the globe.

How can I contact Petmed Express?

Petmed Express' mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The company can be reached via phone at 561-526-4444.


MarketBeat Community Rating for Petmed Express (PETS)

Community Ranking:  1.5 out of 5 (star half star)
Outperform Votes:  100 (Vote Outperform)
Underperform Votes:  224 (Vote Underperform)
Total Votes:  324
MarketBeat's community ratings are surveys of what our community members think about Petmed Express and other stocks. Vote "Outperform" if you believe PETS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PETS will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Petmed Express (NASDAQ:PETS) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
5 Wall Street analysts have issued ratings and price targets for Petmed Express in the last 12 months. Their average twelve-month price target is $40.50, suggesting that the stock has a possible upside of 6.75%. The high price target for PETS is $58.00 and the low price target for PETS is $19.00. There are currently 1 sell rating, 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.202.202.202.20
Ratings Breakdown: 1 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $40.50$41.00$41.00$40.00
Price Target Upside: 6.75% upside12.77% downside12.77% downside14.55% upside

Petmed Express (NASDAQ:PETS) Consensus Price Target History

Price Target History for Petmed Express (NASDAQ:PETS)

Petmed Express (NASDAQ:PETS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/8/2018Craig HallumLower Price TargetHold$38.00LowView Rating Details
1/3/2018Northcoast ResearchSet Price TargetBuy$58.00HighView Rating Details
10/27/2017Noble FinancialReiterated RatingHoldN/AView Rating Details
10/2/2017Credit Suisse GroupReiterated RatingUnderperform$19.00LowView Rating Details
8/24/2017SidotiUpgradeNeutral ➝ Buy$47.00HighView Rating Details
(Data available from 5/26/2016 forward)

Earnings

Petmed Express (NASDAQ:PETS) Earnings History and Estimates Chart

Earnings by Quarter for Petmed Express (NASDAQ:PETS)

Petmed Express (NASDAQ:PETS) Earnings Estimates

2018 EPS Consensus Estimate: $1.51
2019 EPS Consensus Estimate: $2.01
2020 EPS Consensus Estimate: $2.66
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182$0.40$0.40$0.40
Q2 20182$0.28$0.28$0.28
Q3 20182$0.33$0.45$0.39
Q4 20182$0.43$0.44$0.44
Q1 20192$0.51$0.64$0.58
Q2 20192$0.42$0.52$0.47
Q3 20192$0.35$0.51$0.43
Q4 20192$0.45$0.61$0.53
Q1 20201$0.75$0.75$0.75
Q2 20201$0.61$0.61$0.61
Q3 20201$0.59$0.59$0.59
Q4 20201$0.71$0.71$0.71

Petmed Express (NASDAQ PETS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/23/2018$0.63N/AView Earnings Details
5/7/2018Q4$0.47$0.50$68.43 million$67.30 millionViewN/AView Earnings Details
1/22/2018Q3 2018$0.33$0.44$56.76 million$60.10 millionViewListenView Earnings Details
10/23/2017Q2 2018$0.30$0.43$63.41 million$66.70 millionViewN/AView Earnings Details
7/24/2017Q1 2018$0.38$0.45$77.32 million$79.66 millionViewN/AView Earnings Details
5/8/2017Q4 17$0.26$0.37$56.53 million$63.03 millionViewListenView Earnings Details
1/23/2017Q3 2017$0.25$0.24$52.70 million$52.90 millionViewN/AView Earnings Details
10/24/2016Q2$0.26$0.24$58.47 million$60.80 millionViewN/AView Earnings Details
7/25/2016Q1$0.31$0.32$72.90 million$72.49 millionViewN/AView Earnings Details
5/9/2016Q4$0.25$0.27$50.20 million$55.40 millionViewN/AView Earnings Details
1/25/2016Q316$0.25$0.24$49.28 million$50.90 millionViewListenView Earnings Details
10/19/2015Q216$0.20$0.22$58.34 million$56.70 millionViewListenView Earnings Details
7/20/2015Q116$0.28$0.29$73.04 million$71.60 millionViewN/AView Earnings Details
5/4/2015Q415$0.25$0.25$49.11 million$50.00 millionViewN/AView Earnings Details
1/20/2015Q315$0.24$0.24$49.26 million$49.30 millionViewN/AView Earnings Details
10/20/2014Q215$0.21$0.19$61.22 million$57.60 millionViewListenView Earnings Details
7/21/2014Q115$0.25$0.25$74.25 million$72.50 millionViewN/AView Earnings Details
5/5/2014Q414$0.22$0.23$55.02 million$48.60 millionViewN/AView Earnings Details
1/21/2014Q214$0.23$0.23$52.06 million$50.10 millionViewN/AView Earnings Details
10/21/2013Q213$0.22$0.20$60.33 million$80.50 millionViewN/AView Earnings Details
7/22/2013Q1 2013$0.22$0.24$69.55 million$74.20 millionViewN/AView Earnings Details
5/6/2013Q4 2012$0.21$0.23$55.31 million$51.10 millionViewN/AView Earnings Details
1/22/2013Q3 2012$0.17$0.23$49.97 million$49.60 millionViewN/AView Earnings Details
10/22/2012$0.17$0.20ViewN/AView Earnings Details
7/23/2012$0.23$0.20ViewN/AView Earnings Details
5/7/2012$0.18$0.20ViewN/AView Earnings Details
1/23/2012$0.16$0.19ViewN/AView Earnings Details
10/24/2011$0.15$0.19ViewN/AView Earnings Details
7/18/2011$0.24$0.22ViewN/AView Earnings Details
5/9/2011$0.23$0.19ViewN/AView Earnings Details
1/24/2011$0.20$0.20ViewN/AView Earnings Details
10/18/2010Q2 2011$0.26$0.22ViewN/AView Earnings Details
7/19/2010Q1 2011$0.38$0.32ViewN/AView Earnings Details
5/10/2010Q4 2010$0.27$0.27ViewN/AView Earnings Details
1/19/2010Q3 2010$0.23$0.25ViewN/AView Earnings Details
10/19/2009Q2 2010$0.28$0.28ViewN/AView Earnings Details
7/20/2009Q1 2010$0.31$0.36ViewN/AView Earnings Details
5/11/2009Q4 2009$0.22$0.25ViewN/AView Earnings Details
1/20/2009Q3 2009$0.20$0.21ViewN/AView Earnings Details
10/20/2008Q2 2009$0.20$0.25ViewN/AView Earnings Details
7/21/2008Q1 2009$0.27$0.28ViewN/AView Earnings Details
5/12/2008Q4 2008$0.18$0.20ViewN/AView Earnings Details
1/22/2008Q3 2008$0.14$0.18ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Petmed Express (NASDAQ:PETS) Dividend Information

Petmed Express pays an annual dividend of $1.00 per share, with a dividend yield of 2.64%. PETS's most recent quarterly dividend payment was Friday, May 25. Petmed Express pays out 54.95% of its earnings out as a dividend.
Most Recent Dividend:5/25/2018
Annual Dividend:$1.00
Dividend Yield:2.64%
Payout Ratio(s):54.95% (Trailing 12 Months of Earnings)
43.86% (Based on This Year's Estimates)
37.59% (Based on Next Year's Estimates)
51.27% (Based on Cash Flow)
Dividend Payments by Quarter for Petmed Express (NASDAQ:PETS)

Petmed Express (NASDAQ:PETS) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/7/2018quarterly$0.252.92%5/17/20185/18/20185/25/2018
1/22/2018quarterly$0.252.4%2/2/20182/5/20182/16/2018
10/24/2017quarterly$0.202.08%11/3/201711/6/201711/17/2017
7/24/2017quarterly$0.201.66%8/3/20178/7/20178/18/2017
5/8/2017quarterly$0.205/17/20175/19/20175/26/2017
1/23/2017quarterly$0.193.61%2/2/20172/6/20172/17/2017
10/24/2016quarterly$0.193.84%11/3/201611/7/201611/18/2016
7/25/2016quarterly$0.193.71%8/4/20168/8/20168/19/2016
5/9/2016quarterly$0.193.9%5/18/20165/20/20165/27/2016
1/25/2016quarterly$0.184.04%2/4/20162/8/20162/19/2016
10/19/2015quarterly$0.184.28%10/29/201511/2/201511/13/2015
7/20/2015quarterly$0.184.23%7/30/20158/3/20158/14/2015
5/4/2015quarterly$0.184.41%5/13/20155/15/20155/22/2015
1/20/2015quarterly$0.174.2%1/30/20152/3/20152/13/2015
10/20/2014quarterly$0.1710/30/201411/3/201411/14/2014
7/21/2014quarterly$0.174.79%7/31/20148/4/20148/15/2014
5/5/2014quarterly$0.175.22%5/14/20145/16/20145/23/2014
1/30/2014quarterly$0.175.14%2/10/20142/12/20142/21/2014
10/28/2013quarterly$0.174.56%11/6/201311/8/201311/22/2013
7/26/2013quarterly$0.174.16%8/8/20138/12/20138/23/2013
5/3/2013quarterly$0.154.65%5/13/20135/15/20135/24/2013
1/28/2013quarterly$0.154.64%2/6/20132/8/20132/22/2013
(Data available from 1/1/2013 forward)

Insider Trades

Petmed Express (NASDAQ PETS) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 4.00%
Institutional Ownership Percentage: 97.50%
Insider Trading History for Petmed Express (NASDAQ:PETS)
Insider Trading History for Petmed Express (NASDAQ:PETS)

Petmed Express (NASDAQ PETS) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/29/2018Ronald J KornDirectorSell5,000$48.38$241,900.0068,833View SEC Filing  
1/22/2018Menderes AkdagCEOSell10,000$57.00$570,000.00470,000View SEC Filing  
1/11/2018Menderes AkdagCEOSell30,000$51.00$1,530,000.00490,000View SEC Filing  
12/15/2017Gian FulgoniDirectorSell20,000$44.38$887,600.0055,900View SEC Filing  
10/27/2017Ronald J KornDirectorSell1,000$35.57$35,570.0073,833View SEC Filing  
8/1/2017Robert C SchweitzerDirectorSell2,500$49.18$122,950.0088,834View SEC Filing  
7/28/2017Ronald J KornDirectorSell5,000$48.18$240,900.0067,333View SEC Filing  
7/27/2017Bruce S RosenbloomCFOSell6,833$50.18$342,879.9418,534View SEC Filing  
7/27/2017Robert C SchweitzerDirectorSell5,000$48.60$243,000.0083,834View SEC Filing  
5/16/2017Frank J FormicaDirectorSell5,000$35.32$176,600.0046,000View SEC Filing  
5/10/2017Gian FulgoniDirectorSell35,000$32.22$1,127,700.0068,400View SEC Filing  
5/8/2017Bruce S RosenbloomInsiderSell9,000$27.00$243,000.0025,267View SEC Filing  
5/1/2017Bruce S RosenbloomInsiderSell1,500$24.00$36,000.0034,267View SEC Filing  
12/13/2016Menderes AkdagCEOSell10,000$23.00$230,000.00520,000View SEC Filing  
12/9/2016Bruce S RosenbloomInsiderSell1,500$23.00$34,500.0035,767View SEC Filing  
12/7/2016Menderes AkdagCEOSell3,107$22.75$70,684.25532,674View SEC Filing  
11/25/2016Menderes AkdagCEOSell6,274$22.25$139,596.50550,000View SEC Filing  
11/16/2016Frank J FormicaDirectorSell10,000$21.75$217,500.0051,000View SEC Filing  
11/14/2016Bruce S RosenbloomInsiderSell3,000$21.75$65,250.0038,767View SEC Filing  
11/14/2016Menderes AkdagCEOSell40,000$21.63$865,200.00590,000View SEC Filing  
10/10/2016Bruce S RosenbloomInsiderSell1,500$21.00$31,500.0041,767View SEC Filing  
10/10/2016Menderes AkdagCEOSell10,000$21.00$210,000.00600,000View SEC Filing  
9/22/2016Menderes AkdagCEOSell10,000$20.75$207,500.00610,000View SEC Filing  
8/12/2016Bruce S RosenbloomInsiderSell8,000$20.38$163,040.0043,267View SEC Filing  
8/11/2016Robert C SchweitzerDirectorSell3,000$20.59$61,770.0090,334View SEC Filing  
8/9/2016Robert C SchweitzerDirectorSell4,500$20.52$92,340.0094,834View SEC Filing  
8/1/2016Ronald J KornDirectorSell4,000$20.76$83,040.0075,333View SEC Filing  
5/9/2016Bruce S RosenbloomCFOSell5,500$19.54$107,470.0044,767View SEC Filing  
3/30/2016Bruce S RosenbloomCFOSell1,500$18.00$27,000.0046,267View SEC Filing  
3/14/2016Bruce S RosenbloomCFOSell3,000$17.25$51,750.0049,267View SEC Filing  
2/22/2016Ronald J KornDirectorSell5,000$16.76$83,800.0071,833View SEC Filing  
1/22/2016Bruce S RosenbloomCFOSell750$18.50$13,875.0050,767View SEC Filing  
11/20/2015Ronald J KornDirectorSell1,000$17.01$17,010.0076,833View SEC Filing  
7/14/2015Bruce S RosenbloomCFOSell400$18.25$7,300.00View SEC Filing  
7/13/2015Bruce S RosenbloomCFOSell100$18.25$1,825.00View SEC Filing  
6/19/2015Bruce S RosenbloomCFOSell1,000$17.88$17,880.00View SEC Filing  
6/19/2015Menderes AkdagCEOSell8,000$17.75$142,000.00View SEC Filing  
6/4/2015Menderes AkdagCEOSell9,930$17.50$173,775.00View SEC Filing  
5/8/2015Frank J FormicaDirectorSell7,500$16.51$123,825.00View SEC Filing  
4/23/2015Menderes AkdagCEOSell10,000$17.25$172,500.00View SEC Filing  
4/20/2015Menderes AkdagCEOSell10,000$17.00$170,000.00View SEC Filing  
4/13/2015Menderes AkdagCEOSell7,499$16.75$125,608.25View SEC Filing  
4/13/2015Ronald J KornDirectorSell2,000$16.75$33,500.00View SEC Filing  
4/8/2015Menderes AkdagCEOSell2,501$16.75$41,891.75View SEC Filing  
3/30/2015Menderes AkdagCEOSell10,000$16.50$165,000.00View SEC Filing  
3/25/2015Ronald J KornDirectorSell2,000$16.25$32,500.00View SEC Filing  
1/21/2015Menderes AkdagCEOSell60,000$15.63$937,800.00View SEC Filing  
1/20/2015Bruce S RosenbloomCFOSell2,167$15.40$33,371.80View SEC Filing  
8/15/2014Ronald J KornDirectorSell2,000$14.13$28,260.00View SEC Filing  
7/22/2014Bruce S RosenbloomCFOSell1,000$14.13$14,130.00View SEC Filing  
7/21/2014Bruce S RosenbloomCFOSell500$14.00$7,000.00View SEC Filing  
6/12/2014Bruce S RosenbloomCFOSell1,500$13.50$20,250.00View SEC Filing  
9/13/2013Menderes AkdagCEOSell10,000$17.00$170,000.00618,000View SEC Filing  
9/11/2013Bruce S RosenbloomCFOSell6,666$16.21$108,055.86View SEC Filing  
8/14/2013Ronald KornDirectorSell1,000$16.25$16,250.0072,833View SEC Filing  
8/12/2013Ronald KornDirectorSell1,000$16.18$16,180.0073,833View SEC Filing  
7/31/2013Frank J FormicaDirectorSell7,000$16.39$114,730.00View SEC Filing  
7/22/2013Bruce S RosenbloomCFOSell6,250$16.74$104,625.00View SEC Filing  
3/6/2013Ronald J KornDirectorSell2,000$13.50$27,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Petmed Express (NASDAQ PETS) News Headlines

Source:
DateHeadline
Petmed Express Inc (PETS) Receives Consensus Rating of "Hold" from BrokeragesPetmed Express Inc (PETS) Receives Consensus Rating of "Hold" from Brokerages
www.americanbankingnews.com - May 26 at 1:40 AM
Market Trends Toward New Normal in Urstadt Biddle Properties, Scotts Miracle-Gro, Universal, PetMed Express, Westwood Holdings Group, and Wabco — Emerging Consolidated Expectations, Analyst RatingsMarket Trends Toward New Normal in Urstadt Biddle Properties, Scotts Miracle-Gro, Universal, PetMed Express, Westwood Holdings Group, and Wabco — Emerging Consolidated Expectations, Analyst Ratings
finance.yahoo.com - May 24 at 8:12 AM
1-800-PetMeds (PETS) vs. CVS Health (CVS) Financial Contrast1-800-PetMeds (PETS) vs. CVS Health (CVS) Financial Contrast
www.americanbankingnews.com - May 19 at 9:21 PM
Financial Review: HealthWarehouse.com (HEWA) & 1-800-PetMeds (PETS)Financial Review: HealthWarehouse.com (HEWA) & 1-800-PetMeds (PETS)
www.americanbankingnews.com - May 19 at 1:05 PM
Amazon (AMZN) Plans to Open Sixth Fulfillment Center in Ohio (revised)Amazon (AMZN) Plans to Open Sixth Fulfillment Center in Ohio (revised)
finance.yahoo.com - May 16 at 5:52 PM
Reviewing 1-800-PetMeds (PETS) and HealthWarehouse.com (HEWA)Reviewing 1-800-PetMeds (PETS) and HealthWarehouse.com (HEWA)
www.americanbankingnews.com - May 16 at 11:33 AM
Reviewing 1-800-PetMeds (PETS) and CVS Health (CVS)Reviewing 1-800-PetMeds (PETS) and CVS Health (CVS)
www.americanbankingnews.com - May 14 at 11:16 PM
3 Days Left To Cash In On PetMed Express Inc (NASDAQ:PETS) Dividend, Should Investors Buy?3 Days Left To Cash In On PetMed Express Inc (NASDAQ:PETS) Dividend, Should Investors Buy?
finance.yahoo.com - May 13 at 6:41 PM
1-800-PetMeds (PETS) Upgraded to "Buy" at Zacks Investment Research1-800-PetMeds (PETS) Upgraded to "Buy" at Zacks Investment Research
www.americanbankingnews.com - May 9 at 6:47 PM
Q1 2019 EPS Estimates for 1-800-PetMeds Raised by Northcoast Research (PETS)Q1 2019 EPS Estimates for 1-800-PetMeds Raised by Northcoast Research (PETS)
www.americanbankingnews.com - May 9 at 9:43 AM
1-800-PetMeds (PETS) Cut to Hold at ValuEngine1-800-PetMeds (PETS) Cut to Hold at ValuEngine
www.americanbankingnews.com - May 8 at 11:26 PM
Form 8-K PETMED EXPRESS INC For: May 07Form 8-K PETMED EXPRESS INC For: May 07
www.streetinsider.com - May 8 at 5:48 PM
PetMed (PETS) Q4 Earnings Top Estimates, Reorder Sales SolidPetMed (PETS) Q4 Earnings Top Estimates, Reorder Sales Solid
finance.yahoo.com - May 8 at 5:48 PM
1-800-PetMeds (PETS) Downgraded by Zacks Investment Research to "Hold"1-800-PetMeds (PETS) Downgraded by Zacks Investment Research to "Hold"
www.americanbankingnews.com - May 8 at 3:23 PM
1-800-PetMeds (PETS) Price Target Cut to $38.001-800-PetMeds (PETS) Price Target Cut to $38.00
www.americanbankingnews.com - May 8 at 2:46 PM
1-800-PetMeds (PETS) Posts  Earnings Results, Beats Expectations By $0.03 EPS1-800-PetMeds (PETS) Posts Earnings Results, Beats Expectations By $0.03 EPS
www.americanbankingnews.com - May 7 at 11:30 AM
1-800-PetMeds (PETS) Declares Quarterly Dividend of $0.251-800-PetMeds (PETS) Declares Quarterly Dividend of $0.25
www.americanbankingnews.com - May 7 at 9:12 AM
PetMed Express, Inc. D/B/A 1-800-PetMeds Announces Record Earnings for its 4th Fiscal Quarter and its Quarterly ...PetMed Express, Inc. D/B/A 1-800-PetMeds Announces Record Earnings for its 4th Fiscal Quarter and its Quarterly ...
www.nasdaq.com - May 7 at 8:13 AM
PetMed Express, Inc. to Host Earnings CallPetMed Express, Inc. to Host Earnings Call
finance.yahoo.com - May 7 at 8:13 AM
PetMed Express, Inc. D/B/A 1-800-PetMeds Announces Record Earnings for its 4th Fiscal Quarter and its Quarterly Dividend of $0.25 per SharePetMed Express, Inc. D/B/A 1-800-PetMeds Announces Record Earnings for its 4th Fiscal Quarter and its Quarterly Dividend of $0.25 per Share
finance.yahoo.com - May 7 at 8:13 AM
Head-To-Head Analysis: Express Scripts (ESRX) versus 1-800-PetMeds (PETS)Head-To-Head Analysis: Express Scripts (ESRX) versus 1-800-PetMeds (PETS)
www.americanbankingnews.com - May 6 at 3:20 PM
Comparing 1-800-PetMeds (PETS) & HealthWarehouse.com (HEWA)Comparing 1-800-PetMeds (PETS) & HealthWarehouse.com (HEWA)
www.americanbankingnews.com - May 5 at 10:10 AM
ValuEngine Upgrades 1-800-PetMeds (PETS) to "Buy"ValuEngine Upgrades 1-800-PetMeds (PETS) to "Buy"
www.americanbankingnews.com - May 2 at 10:54 PM
1-800-PetMeds (PETS) Given Consensus Rating of "Hold" by Analysts1-800-PetMeds (PETS) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - May 1 at 1:26 AM
PetMed Express D/B/A 1-800-PetMeds to Announce Its Fiscal Year End Financial Results on May 7, 2018PetMed Express D/B/A 1-800-PetMeds to Announce Its Fiscal Year End Financial Results on May 7, 2018
finance.yahoo.com - April 30 at 8:14 AM
1-800-PetMeds (PETS) to Release Quarterly Earnings on Monday1-800-PetMeds (PETS) to Release Quarterly Earnings on Monday
www.americanbankingnews.com - April 30 at 2:56 AM
PetMed Express (PETS) is Oversold: Can It Recover?PetMed Express (PETS) is Oversold: Can It Recover?
finance.yahoo.com - April 26 at 5:22 PM
 Brokerages Anticipate 1-800-PetMeds (PETS) Will Post Quarterly Sales of $67.55 Million Brokerages Anticipate 1-800-PetMeds (PETS) Will Post Quarterly Sales of $67.55 Million
www.americanbankingnews.com - April 26 at 4:34 AM
PetMed Express Inc (NASDAQ:PETS) Investors Are Paying Above The Intrinsic ValuePetMed Express Inc (NASDAQ:PETS) Investors Are Paying Above The Intrinsic Value
finance.yahoo.com - April 25 at 8:11 AM
1-800-PetMeds (PETS) Stock Rating Lowered by BidaskClub1-800-PetMeds (PETS) Stock Rating Lowered by BidaskClub
www.americanbankingnews.com - April 25 at 12:24 AM
 Brokerages Expect 1-800-PetMeds (PETS) to Announce $0.44 Earnings Per Share Brokerages Expect 1-800-PetMeds (PETS) to Announce $0.44 Earnings Per Share
www.americanbankingnews.com - April 24 at 8:08 AM
The Zacks Analyst Blog Highlights: Etsy, eBay, Amazon and PetMed ExpressThe Zacks Analyst Blog Highlights: Etsy, eBay, Amazon and PetMed Express
finance.yahoo.com - April 20 at 5:28 PM
Contrasting 1-800-PetMeds (PETS) & Express Scripts (ESRX)Contrasting 1-800-PetMeds (PETS) & Express Scripts (ESRX)
www.americanbankingnews.com - April 18 at 5:15 PM
1-800-PetMeds (PETS) Rating Lowered to Hold at BidaskClub1-800-PetMeds (PETS) Rating Lowered to Hold at BidaskClub
www.americanbankingnews.com - April 18 at 9:51 AM
Is PetMed Express Inc (NASDAQ:PETS) A Smart Choice For Dividend Investors?Is PetMed Express Inc (NASDAQ:PETS) A Smart Choice For Dividend Investors?
finance.yahoo.com - April 17 at 8:20 AM
Financial Review: 1-800-PetMeds (PETS) & Express Scripts (ESRX)Financial Review: 1-800-PetMeds (PETS) & Express Scripts (ESRX)
www.americanbankingnews.com - April 14 at 5:11 PM
1-800-PetMeds (PETS) Rating Lowered to Hold at ValuEngine1-800-PetMeds (PETS) Rating Lowered to Hold at ValuEngine
www.americanbankingnews.com - April 13 at 11:10 PM
Comparing 1-800-PetMeds (PETS) and Express Scripts (ESRX)Comparing 1-800-PetMeds (PETS) and Express Scripts (ESRX)
www.americanbankingnews.com - April 13 at 7:19 PM
1-800-PetMeds (PETS) Expected to Announce Quarterly Sales of $67.84 Million1-800-PetMeds (PETS) Expected to Announce Quarterly Sales of $67.84 Million
www.americanbankingnews.com - April 9 at 3:44 AM
Walgreens Boots Alliance (WBA) versus 1-800-PetMeds (PETS) Critical SurveyWalgreens Boots Alliance (WBA) versus 1-800-PetMeds (PETS) Critical Survey
www.americanbankingnews.com - April 8 at 11:23 AM
1-800-PetMeds (PETS) Downgraded by ValuEngine1-800-PetMeds (PETS) Downgraded by ValuEngine
www.americanbankingnews.com - April 8 at 11:17 AM
1-800-PetMeds (PETS) Expected to Announce Earnings of $0.44 Per Share1-800-PetMeds (PETS) Expected to Announce Earnings of $0.44 Per Share
www.americanbankingnews.com - April 7 at 8:08 AM
1-800-PetMeds (PETS) Receives Consensus Recommendation of "Hold" from Analysts1-800-PetMeds (PETS) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - April 6 at 1:36 AM
1-800-PetMeds (PETS) and Walgreens Boots Alliance (WBA) Critical Analysis1-800-PetMeds (PETS) and Walgreens Boots Alliance (WBA) Critical Analysis
www.americanbankingnews.com - April 4 at 9:21 PM
1-800-PetMeds (PETS) Lifted to Buy at ValuEngine1-800-PetMeds (PETS) Lifted to Buy at ValuEngine
www.americanbankingnews.com - April 3 at 10:33 AM
1-800-PetMeds (PETS) vs. Walgreens Boots Alliance (WBA) Financial Survey1-800-PetMeds (PETS) vs. Walgreens Boots Alliance (WBA) Financial Survey
www.americanbankingnews.com - April 2 at 7:16 PM
Should You Buy PetMed Express Inc (NASDAQ:PETS)?Should You Buy PetMed Express Inc (NASDAQ:PETS)?
finance.yahoo.com - March 30 at 5:38 PM
Amazon Teams Up With Monoprix, Bolsters Presence in EuropeAmazon Teams Up With Monoprix, Bolsters Presence in Europe
finance.yahoo.com - March 27 at 5:20 PM
Petmed Express (PETS) Rating Increased to Buy at ValuEnginePetmed Express (PETS) Rating Increased to Buy at ValuEngine
www.americanbankingnews.com - March 25 at 11:21 AM
$67.84 Million in Sales Expected for Petmed Express Inc (PETS) This Quarter$67.84 Million in Sales Expected for Petmed Express Inc (PETS) This Quarter
www.americanbankingnews.com - March 23 at 9:36 AM

SEC Filings

Petmed Express (NASDAQ:PETS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Petmed Express (NASDAQ:PETS) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Petmed Express (NASDAQ PETS) Stock Chart for Saturday, May, 26, 2018

Loading chart…

This page was last updated on 5/26/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.